Skip to content

PHARMACEUTICAL MANAGEMENT & CONSULTANCY

abbreviatedPHARMANCO
Absorbed by BIOVER II on 14-01-2011 KBO/BCE: BE 0453.223.689

Lifetime

4 annual accounts with figures on one time axis, 16 filings since 1995
peak of €45,862 in 2007
-€7,275▲ €6,011
lowest -€7,646 in 2010
-€7,646▼ €74,529
peak of €6.8m in 2009
€6.7m▼ 0.1%
€869,128▲ 0.7%
Owners2 names in the annual accounts
  
Documentsfilings and deeds
30-11-2010filed
2010abbreviated format
Gross margin from -€13,286 to -€7,275Loss of €7,646Merger proposal: to be absorbed by Biover II 16-11Capital increase of €812,500 to €7,312,500 08-092 directors appointed, 4 resignations 09-04Cash from €2,796 to €1,151

Key points

from the 2010 annual accounts, the last ones filed

Result

-€7,646 -€7,646
€66,9002009-€7,6502010

From profit to loss in 2010, after a profit of €66,883 in 2009.

Filings

16 annual accounts since 1995
deadline1995200020052010

The last five annual accounts were filed 42 to 62 days before the end of the period.

Turnover not published in the abbreviated format

Board and ownership

last known board
Managing director, last mentioned in 2010
Director, until 2010
Director, until 2010
Director, until 2010
Director, until 2010
Board & ownership

Recent changes

Merger: absorbed by BIOVER II BIOVER II holds all the shares · Gazette deed
Merger proposal: to be absorbed by Biover II Gazette deed
Capital increase of €812,500 to €7,312,500 The capital rose from €6,500,000 to €7,312,500 · Gazette deed
2 directors appointed, 4 resignations , , and Biover II Bvba resign · (managing director) and Biover II Bvba appointed · , and act as permanent representatives · General meeting of 05-03-2010 · Gazette deed
All 26 events

Official details

Source: KBO
Status
Absorbed by BIOVER IImerger by absorption, January 2011
Activity
No activity registered in the KBO
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2010

€7.6m=
Filing
Filed on 30-11-2010
Financials

Insights on PHARMACEUTICAL MANAGEMENT & CONSULTANCY

Absorbed by BIOVER II in January 2011. The last annual accounts are for financial year 2010.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACEUTICAL MANAGEMENT & CONSULTANCY

What is the company number of PHARMACEUTICAL MANAGEMENT & CONSULTANCY?
The company number of PHARMACEUTICAL MANAGEMENT & CONSULTANCY is 0453.223.689. The VAT number is the same number with BE in front: BE 0453.223.689.
What is the legal form of PHARMACEUTICAL MANAGEMENT & CONSULTANCY?
The KBO register gives PHARMACEUTICAL MANAGEMENT & CONSULTANCY the legal form “NV”.
Is PHARMACEUTICAL MANAGEMENT & CONSULTANCY still active?
No. Absorbed in a merger on 14-01-2011.Company details
What is the turnover of PHARMACEUTICAL MANAGEMENT & CONSULTANCY?
The annual accounts for financial year 2010 state no turnover. The abbreviated format does not require it.Financials
Is PHARMACEUTICAL MANAGEMENT & CONSULTANCY profitable?
In financial year 2010, PHARMACEUTICAL MANAGEMENT & CONSULTANCY made a loss of €7,646.
Where can I find the annual accounts of PHARMACEUTICAL MANAGEMENT & CONSULTANCY?
PHARMACEUTICAL MANAGEMENT & CONSULTANCY filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2010.

Next steps

Keep this company with today's facts in a case file.